Immatics (IMTX) Non Operating Interest Expenses (2019 - 2026)
Powered by 
Analysis
Immatics (IMTX) Non Operating Interest Expenses (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.58 Bn | 130.73 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.33 Bn | 77.33 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.43 Bn | 58.24 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 57.84 Bn | 52.70 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 39.93 Bn | 34.83 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.39 Bn | 27.56 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Immatics | 1.15 Bn | 696.53 Mn | - | -423,099.71 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -423,099.71 |
| Mar 31, 2026 | -522,152.56 |
| Dec 31, 2025 | -599,482.41 |
| Sep 30, 2025 | -337,856.92 |
| Jun 30, 2025 | -25.78 Mn |
| Mar 31, 2025 | -14.03 Mn |
| Dec 31, 2024 | 4.30 Mn |
| Sep 30, 2024 | -13.83 Mn |
| Jun 30, 2024 | -328,450.71 |
| Mar 31, 2024 | -735,466.92 |
| Dec 31, 2023 | -3.11 Mn |
| Sep 30, 2023 | -1.71 Mn |
| Jun 30, 2023 | -1.25 Mn |
| Mar 31, 2023 | -3.77 Mn |
| Dec 31, 2022 | -6.46 Mn |
| Sep 30, 2022 | -429,524.86 |
| Jun 30, 2022 | -434,292.07 |
| Mar 31, 2022 | -1.25 Mn |
| Dec 31, 2021 | -372,934.53 |
| Sep 30, 2021 | -201,658.13 |